Single-Pathway Interventions
A POTS medication lowered heart rate but did not improve patients' subjective symptoms. Trials of interventions targeting one biochemical pathway have generally produced weak or null results. CoQ10 failed to improve symptoms in clinical tr…
1 sources - 4 claims
A POTS medication lowered heart rate but did not improve patients' subjective symptoms. Trials of interventions targeting one biochemical pathway have generally produced weak or null results. CoQ10 failed to improve symptoms in clinical trials despite a plausible mitochondrial rationale. Timelimab failed in a large controlled trial despite promising early data and a plausible mechanism.